| scholarly article | Q13442814 |
| P50 | author | Chris Fox | Q56591097 |
| Nicholas J. Wareham | Q56936055 | ||
| Phyo Kyaw Myint | Q114409016 | ||
| Kay-Tee Khaw | Q28356290 | ||
| Robert N. Luben | Q30506463 | ||
| Chun Shing Kwok | Q37841809 | ||
| P2860 | cites work | Anticholinergic activity of 107 medications commonly used by older adults | Q46569221 |
| The duration of impairment of autonomic control after anticholinergic drug administration in humans. | Q51554384 | ||
| Effects of potent anticholinergics, sedatives and antipsychotics on postoperative mortality in elderly patients with hip fracture: a retrospective, population-based study. | Q51861790 | ||
| EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer | Q57202839 | ||
| Concomitant use of cholinesterase inhibitors and anticholinergics: prevalence and outcomes | Q82545111 | ||
| Anticholinergic drug use and mortality among residents of long-term care facilities: a prospective cohort study | Q84271149 | ||
| Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications | Q22306481 | ||
| Accuracy of death certification and hospital record linkage for identification of incident stroke | Q33383617 | ||
| The impact of anticholinergic burden in Alzheimer's dementia-the LASER-AD study | Q34021666 | ||
| Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis | Q34835363 | ||
| Anticholinergic drugs and their effects on delirium and mortality in the elderly | Q35428172 | ||
| Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study | Q37039179 | ||
| Role of muscarinic receptors in the regulation of immune and inflammatory responses | Q43125159 | ||
| Associations between drug burden index and mortality in older people in residential aged care facilities | Q44670916 | ||
| Measures of anticholinergic drug exposure, serum anticholinergic activity, and all-cause postdischarge mortality in older hospitalized patients with hip fractures | Q44818885 | ||
| Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study | Q44926630 | ||
| Association of anticholinergic drugs with hospitalization and mortality among older cardiovascular patients: A prospective study. | Q46004691 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cardiovascular disease | Q389735 |
| cardiovascular disease in women | Q105047283 | ||
| P304 | page(s) | 219-225 | |
| P577 | publication date | 2014-11-27 | |
| P1433 | published in | Age and Ageing | Q4691852 |
| P1476 | title | Total anticholinergic burden and risk of mortality and cardiovascular disease over 10 years in 21,636 middle-aged and older men and women of EPIC-Norfolk prospective population study | |
| P478 | volume | 44 |
| Q48104871 | Anticholinergic Accumulation: A Slumbering Interaction between Drugs and Food Supplements |
| Q38963603 | Anticholinergic Medication Use and Fractures in Postmenopausal Women: Findings from the Women's Health Initiative |
| Q48324819 | Anticholinergic burden and 1-year mortality among older patients discharged from acute care hospital. |
| Q92794654 | Anticholinergic burden and fractures: a protocol for a methodological systematic review and meta-analysis |
| Q48308894 | Anticholinergic burden and health outcomes among older adults discharged from hospital: results from the CRIME study. |
| Q91564630 | Anticholinergic burden before and after hospitalization in older adults with dementia: Increase due to antipsychotic medications |
| Q39650906 | Anticholinergic medicines in an older primary care population: a cross-sectional analysis of medicines' levels of anticholinergic activity and clinical indications |
| Q90089092 | Are antidementia drugs associated with reduced mortality after a hospital emergency admission in the population with dementia aged 65 years and older? |
| Q38814164 | Association of Anticholinergic Burden with Cognitive Impairment and Health Care Utilization Among a Diverse Ambulatory Older Adult Population |
| Q38946891 | Audit of anticholinergic medication changes in older hospitalised patients using the Anticholinergic Drug Scale |
| Q49922706 | Baseline anticholinergic burden from medications predicts incident fatal and non-fatal stroke in the EPIC-Norfolk general population. |
| Q33665026 | CUA guideline on adult overactive bladder |
| Q47604480 | Comparative Associations Between Measures of Anti-cholinergic Burden and Adverse Clinical Outcomes |
| Q99570614 | Impact of Anticholinergic Medication Burden on Mobility and Falls in the Lifestyle Interventions for Elders (LIFE) Study |
| Q28072230 | Mirabegron in overactive bladder patients: efficacy review and update on drug safety |
| Q64900844 | Polypharmacy in an Elderly Population: Enhancing Medication Management Through the Use of Clinical Decision Support Software Platforms. |
| Q38705840 | Risk of Mortality Associated with Anticholinergic Use in Elderly Nursing Home Residents with Depression. |
| Q64896157 | Stroke and Falls-Clash of the Two Titans in Geriatrics. |
Search more.